One of the challenges in cancer treatment is the development of drug resistance. Overexpression of DHFR is one mechanism by which cancer cells can become resistant to DHFR inhibitors like methotrexate. Studying the histological and molecular aspects of DHFR expression in tumors can help in understanding and potentially overcoming this resistance.
